Jasper Therapeutics, Inc. (NASDAQ:JSPR) Receives Consensus Recommendation of “Buy” from Brokerages
Shares of Jasper Therapeutics, Inc. (NASDAQ:JSPR – Get Free Report) have earned an average rating of “Buy” from the eleven analysts that are covering the company, Marketbeat reports. Eleven investment analysts have rated the stock with a buy rating. The average 12 month price target among brokers that have issued ratings on the stock in […]
Shares of Jasper Therapeutics, Inc. (NASDAQ:JSPR – Get Free Report) have earned an average rating of “Buy” from the eleven analysts that are covering the company, Marketbeat reports. Eleven investment analysts have rated the stock with a buy rating. The average 12 month price target among brokers that have issued ratings on the stock in […]
